NASDAQ · SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. · MID CAP
Health Catalyst, Inc. HCAT
9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$311.1M
▲ 1.5% vs FY2024
EPS · FY25
$-2.55
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-58.3%
Net margin · FY25
-57.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 311.1M
Revenue, FY2025 · full 9-year series below
Revenue
Net income
The company lost 57 cents on every revenue dollar this year.
Per share
USD -2.55
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-58.3%
Return on equity, FY2025
ROE
Operating margin-51.7%
Net margin-57.2%
Return on assets-26.1%
Each USD of equity lost 58 cents this year.
Returned to shareholders
USD 5.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 5.0M
Share of profit-2.8%
Consecutive raises—
USD 5.0M in buybacks went back to shareholders in a year without profit.
Growth
+10.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+4.0%
+10.5%
Returned to shareholders
+4.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years+66.1%
Change, 10 years—
The share count grew 66% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 502.6M
total assets, end of FY2025
Total assetsUSD 502.6M
EquityUSD 245.8M
CashUSD 50.8M
Gross debtUSD 153.3M
Net debtUSD 102.4M
Current ratio1.89×
Net debt stands at 42% of equity.
History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0.1
Operating income $B
−0.2
−0.1
−0.1
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
EBITDA $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
Income tax $B
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
0.0
Net income $B
−0.2
−0.1
−0.1
−0.1
−0.2
−0.1
−0.1
−0.1
−0.0
EPS, diluted $
−2.55
−1.15
−2.09
−2.63
−3.23
−2.91
−12.86
−23.76
−12.13
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−58.3
−19.0
−29.8
−29.0
−38.4
−48.3
·
·
·
Shares out B
0.07
0.06
0.06
0.06
0.05
0.04
0.04
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
25 of 25
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed